Abstract:In these studies, we designed and investigated the potential anticancer activity of five iron(II) cyclopentadienyl complexes bearing different phosphine and phosphite ligands. All complexes were characterized with spectroscopic analysis viz. NMR, FT–IR, ESI–MS, UV–Vis, fluorescence, XRD (for four complexes) and elemental analyses. For biological studies, we used three types of cells—normal peripheral blood mononuclear (PBM) cells, leukemic HL-60 cells and non-small-cell lung cancer A549 cells. We evaluated cell viability and DNA damage after cell incubation with these complexes. We observed that all iron(II) complexes were more cytotoxic for HL-60 cells than for A549 cells. The complex CpFe(CO)(P(OPh) 3 )(η 1 - N -maleimidato) 3b was the most cytotoxic with IC 50 = 9.09 μM in HL-60 cells, IC 50 = 19.16 μM in A549 and IC 50 = 5.80 μM in PBM cells. The complex CpFe(CO)(P(Fu) 3 )(η 1 - N -maleimidato) 2b was cytotoxic only for both cancer cell lines, with IC 50 = 10.03 μM in HL-60 cells and IC 50 = 73.54 μM in A549 cells. We also found the genotoxic potential of the complex 2b in both types of cancer cells. However, the complex CpFe(CO) 2 (η 1 - N -maleimidato) 1 which we studied previously, was much more genotoxic than complex 2b , especially for A549 cells. The plasmid relaxation assay showed that iron(II) complexes do not induce strand breaks in fully paired ds-DNA. The DNA titration experiment showed no intercalation of complex 2b into DNA. Molecular docking revealed however that complexes CpFe(CO)(PPh 3 ) (η 1 - N -maleimidato) 2a , 2b , 3b and CpFe(CO)(P(O i Pr) 3 )(η 1 - N -maleimidato) 3c have the greatest potential to bind to mismatched DNA. Our studies demonstrated that the iron(II) complex 1 and 2b are the most interesting compounds in terms of selective cytotoxic action against cancer cells. However, the cellular mechanism of their anticancer activity requires further research.

Exploiting Co(III)-Cyclopentadienyl Complexes To Develop Anticancer Agents

Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor

Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp 2 -N/sp 3 -N Donor Ligands to Achieve Improved Anticancer Selectivity

Dithiocarbazate–Fe III , −Co III , −Ni II , and −Zn II Complexes: Design, Synthesis, Structure, and Anticancer Evaluation

Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands

Self-Assembling Metallocomplexes of the Amphiphilic 1,4-Diazabicyclo[2.2.2]octane Derivative as a Platform for the Development of Nonplatinum Anticancer Drugs

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study

Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds

Metal-N-heterocyclic carbene complexes as anti-tumor agents

Crystal Structure, Anticancer, and Antimicrobial Evaluation of a Novel Substituted Pyrazole Ligand and Its Co(II), Ni(II), and Zn(II) Complexes

Semisandwich cobalt(III) complexes as antitumor agents: high intracellular ROS activity and low in vivo toxicity

The influence of thioether-substituted ligands in dicopper(II) complexes: Enhancing oxidation and biological activities

Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer

Catalytic and Pharmacological Activity

Synthesis and Investigations of the Antitumor Effects of First-Row Transition Metal(II) Complexes Supported by Two Fluorinated and Non-Fluorinated β-Diketonates

Novel half Salphen cobalt(III) complexes: synthesis, DNA binding and anticancer studies

Antitumor Activity of Pt(II), Ru(III) and Cu(II) Complexes

Potent Half-Sandwich 16-/18-Electron Iridium(III) and Ruthenium(II) Anticancer Complexes with Readily Available Amine-Imine Ligands

Synthesis and Anti-Cancer Investigations of Copper(II) Complexes Based on Adenine